Completed

4

177

Europe

Eleclazine white 10 mg tablets, Eleclazine white 3 mg tablets, Eleclazine white 6 mg tablets, Eleclazine pink 6 mg tablets, GS-6615 white 10 mg tablets, GS-6615 white 3 mg tablets, GS-6155 white 6 mg tablets, GS-6615 pink 6 mg tablets, Film-coated tablet

Gilead Sciences, Inc., GILEAD SCIENCES INCORPORATED, Gilad Sciences, Inc.

The goal of this study is to follow up with female subjects who received eleclazine in prior clinical trials for ischemic heart disease, ventricular arrhythmia, hypertrophic cardiomyopathy or long QT syndrome., Study to follow up with female subjects who received eleclazine in prior clinical trials for ischemic heart disease, ventricular arrhythmia, hypertrophic cardiomyopathy or long QT syndrome., Diseases [C] - Cardiovascular Diseases [C14]